Innoviva, Inc. (INVA)
20.98
+0.02
(+0.10%)
USD |
NASDAQ |
Aug 28, 16:00
20.98
0.00 (0.00%)
After-Hours: 19:32
Innoviva Cash from Operations (Quarterly) : 51.97M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.97M |
| March 31, 2026 | 35.28M |
| December 31, 2025 | 54.51M |
| September 30, 2025 | 49.73M |
| June 30, 2025 | 44.07M |
| March 31, 2025 | 48.62M |
| December 31, 2024 | 59.24M |
| September 30, 2024 | 48.69M |
| June 30, 2024 | 43.72M |
| March 31, 2024 | 37.05M |
| December 31, 2023 | 33.26M |
| September 30, 2023 | 43.94M |
| June 30, 2023 | 38.18M |
| March 31, 2023 | 25.68M |
| December 31, 2022 | 8.899M |
| September 30, 2022 | 15.69M |
| June 30, 2022 | 79.04M |
| March 31, 2022 | 98.10M |
| December 31, 2021 | 98.38M |
| September 30, 2021 | 96.71M |
| June 30, 2021 | 84.61M |
| March 31, 2021 | 84.11M |
| December 31, 2020 | 85.28M |
| September 30, 2020 | 74.56M |
| June 30, 2020 | 79.79M |
| Date | Value |
|---|---|
| March 31, 2020 | 73.48M |
| December 31, 2019 | 66.90M |
| September 30, 2019 | 57.40M |
| June 30, 2019 | 56.50M |
| March 31, 2019 | 76.66M |
| December 31, 2018 | 61.78M |
| September 30, 2018 | 60.12M |
| June 30, 2018 | 51.72M |
| March 31, 2018 | 49.91M |
| December 31, 2017 | 47.86M |
| September 30, 2017 | 43.49M |
| June 30, 2017 | 22.64M |
| March 31, 2017 | 27.76M |
| December 31, 2016 | 21.09M |
| September 30, 2016 | 20.19M |
| June 30, 2016 | 12.46M |
| March 31, 2016 | 7.25M |
| December 31, 2015 | 6.917M |
| September 30, 2015 | 2.656M |
| June 30, 2015 | 2.174M |
| March 31, 2015 | -1.616M |
| December 31, 2014 | -4.61M |
| September 30, 2014 | -21.07M |
| June 30, 2014 | -54.40M |
| March 31, 2014 | -50.64M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 17.03M |
| Collegium Pharmaceutical, Inc. | 71.32M |
| CorMedix, Inc. | 86.06M |
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 33.54M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -55.26M |
| Cash from Financing (Quarterly) | -29.40M |
| Free Cash Flow | 189.44M |
| Free Cash Flow Per Share (Quarterly) | 0.702 |
| Free Cash Flow to Equity (Quarterly) | 108.61M |
| Free Cash Flow to Firm (Quarterly) | 55.77M |
| Free Cash Flow Yield | 11.00% |